{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-019831","form_type":"8-K","ticker":"PVLA","cik":"0001583648","company_name":"PALVELLA THERAPEUTICS, INC.","filed_at":"2023-07-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.431645+00:00","generated_at":"2026-06-13T08:44:18.330542+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Chief Business Officer Ahmed Mousa resigns to become CEO of Vicore Pharma","bullets":["Ahmed Mousa to resign as SVP, Chief Business Officer, General Counsel & Corporate Secretary effective September 11, 2023.","Resignation to become CEO of Vicore Pharma Holding AB; no disagreement with Pieris on any matter.","CEO Stephen Yoder will oversee corporate and business development following Mousa's departure.","Mousa expected to serve as strategic advisor for a transition period subject to mutual terms."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-019831","json":"https://secwatch.observer/filing/0001437749-23-019831.json","markdown":"https://secwatch.observer/filing/0001437749-23-019831.md","text":"https://secwatch.observer/filing/0001437749-23-019831.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583648/000143774923019831/0001437749-23-019831-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583648/000143774923019831/pirs20230705c_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T08:44:18.330542+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"710b67f907","claim":"Ahmed Mousa resigned as Senior Vice President, Chief Business Officer, General Counsel & Corporate Secretary at PALVELLA THERAPEUTICS, INC..","evidence_excerpt":"On July 13, 2023, Ahmed Mousa, the Senior Vice President, Chief Business Officer, General Counsel & Corporate Secretary of Pieris Pharmaceuticals, Inc. (the “Company”), gave notice that he will resign from the Company effective September 11, 2023 in order to become chief executive officer of Vicore Pharma Holding AB.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1583648/000143774923019831/0001437749-23-019831-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Senior Vice President, Chief Business Officer, General Counsel & Corporate Secretary"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}